The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Flu Vaccine-Global Market Insights and Sales Trends 2025
Synopsis
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
The global Flu Vaccine market size is expected to reach US$ 7673.2 million by 2029, growing at a CAGR of 4.8% from 2023 to 2029. The market is mainly driven by the significant applications of Flu Vaccine in various end use industries. The expanding demands from the For Children (6 months to 3 years) and For Adults and Children over 3 years, are propelling Flu Vaccine market. Trivalent Influenza Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Quadrivalent Influenza Vaccine segment is estimated at % CAGR for the next seven-year period.
Global Flu Vaccine key players include Sanofi Pasteur, CSL, GSK, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, Quadrivalent Influenza Vaccine is the largest segment, with a share nearly 85%. And in terms of application, the largest application is For Adults and Children over 3 years, followed by For Children (6 months to 3 years).
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Flu Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Flu Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Flu Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Flu Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Flu Vaccine covered in this report include Sanofi Pasteur, CSL, GSK, Mylan, Hulan Bio, AstraZeneca and CCBIO, etc.
The global Flu Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi Pasteur
CSL
GSK
Mylan
Hulan Bio
AstraZeneca
CCBIO
Global Flu Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Flu Vaccine market, Segment by Type:
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Global Flu Vaccine market, by Application
For Children (6 months to 3 years)
For Adults and Children over 3 years
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Flu Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Flu Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Influenza vaccines, also known as flu shots, are vaccines that protect against influenza. A new version of the vaccine is developed twice a year as the influenza virus rapidly changes. Most provide modest to high protection against influenza; however, each year this varies. Evidence in adults over 65 years old is poor. They decrease the number of missed days of work by a half day on average. Vaccinating children may protect those around them.
The global Flu Vaccine market size is expected to reach US$ 7673.2 million by 2029, growing at a CAGR of 4.8% from 2023 to 2029. The market is mainly driven by the significant applications of Flu Vaccine in various end use industries. The expanding demands from the For Children (6 months to 3 years) and For Adults and Children over 3 years, are propelling Flu Vaccine market. Trivalent Influenza Vaccine, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Quadrivalent Influenza Vaccine segment is estimated at % CAGR for the next seven-year period.
Global Flu Vaccine key players include Sanofi Pasteur, CSL, GSK, etc. Global top three manufacturers hold a share over 75%.
North America is the largest market, with a share about 40%, followed by Europe, and Asia-Pacific, both have a share about 45 percent.
In terms of product, Quadrivalent Influenza Vaccine is the largest segment, with a share nearly 85%. And in terms of application, the largest application is For Adults and Children over 3 years, followed by For Children (6 months to 3 years).
Report Objectives
This report provides market insight on the different segments, by manufacturers, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Flu Vaccine, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Flu Vaccine market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Flu Vaccine market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Flu Vaccine sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Flu Vaccine covered in this report include Sanofi Pasteur, CSL, GSK, Mylan, Hulan Bio, AstraZeneca and CCBIO, etc.
The global Flu Vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Sanofi Pasteur
CSL
GSK
Mylan
Hulan Bio
AstraZeneca
CCBIO
Global Flu Vaccine market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Flu Vaccine market, Segment by Type:
Trivalent Influenza Vaccine
Quadrivalent Influenza Vaccine
Global Flu Vaccine market, by Application
For Children (6 months to 3 years)
For Adults and Children over 3 years
Core Chapters
Chapter One: Introduces the study scope of this report, executive summary of market segments by Type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Two: Detailed analysis of Flu Vaccine manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Three: Sales, revenue of Flu Vaccine in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.
Chapter Four: Introduces market segments by Application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.
Chapter Five, Six, Seven, Eight and Nine: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.
Chapter Ten: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter Eleven: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics. Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Analysis of sales channel, distributors and customers.
Chapter Thirteen: Research Findings and Conclusion.
Index1 Flu Vaccine Market Overview
1.1 Flu Vaccine Product Overview
1.2 Flu Vaccine Market Segment by Type
1.2.1 Trivalent Influenza Vaccine
1.2.2 Quadrivalent Influenza Vaccine
1.3 Global Flu Vaccine Market Size by Type
1.3.1 Global Flu Vaccine Market Size Overview by Type (2018-2029)
1.3.2 Global Flu Vaccine Historic Market Size Review by Type (2018-2023)
1.3.3 Global Flu Vaccine Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Flu Vaccine Sales Breakdown by Type (2018-2023)
1.4.2 Europe Flu Vaccine Sales Breakdown by Type (2018-2023)
1.4.3 Asia-Pacific Flu Vaccine Sales Breakdown by Type (2018-2023)
1.4.4 Latin America Flu Vaccine Sales Breakdown by Type (2018-2023)
1.4.5 Middle East and Africa Flu Vaccine Sales Breakdown by Type (2018-2023)
2 Global Flu Vaccine Market Competition by Company
2.1 Global Top Players by Flu Vaccine Sales (2018-2023)
2.2 Global Top Players by Flu Vaccine Revenue (2018-2023)
2.3 Global Top Players by Flu Vaccine Price (2018-2023)
2.4 Global Top Manufacturers Flu Vaccine Manufacturing Base Distribution, Sales Area, Product Type
2.5 Flu Vaccine Market Competitive Situation and Trends
2.5.1 Flu Vaccine Market Concentration Rate (2018-2023)
2.5.2 Global 5 and 10 Largest Manufacturers by Flu Vaccine Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Flu Vaccine as of 2022)
2.7 Date of Key Manufacturers Enter into Flu Vaccine Market
2.8 Key Manufacturers Flu Vaccine Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Flu Vaccine Status and Outlook by Region
3.1 Global Flu Vaccine Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Flu Vaccine Historic Market Size by Region
3.2.1 Global Flu Vaccine Sales in Volume by Region (2018-2023)
3.2.2 Global Flu Vaccine Sales in Value by Region (2018-2023)
3.2.3 Global Flu Vaccine Sales (Volume & Value) Price and Gross Margin (2018-2023)
3.3 Global Flu Vaccine Forecasted Market Size by Region
3.3.1 Global Flu Vaccine Sales in Volume by Region (2024-2029)
3.3.2 Global Flu Vaccine Sales in Value by Region (2024-2029)
3.3.3 Global Flu Vaccine Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Flu Vaccine by Application
4.1 Flu Vaccine Market Segment by Application
4.1.1 For Children (6 months to 3 years)
4.1.2 For Adults and Children over 3 years
4.2 Global Flu Vaccine Market Size by Application
4.2.1 Global Flu Vaccine Market Size Overview by Application (2018-2029)
4.2.2 Global Flu Vaccine Historic Market Size Review by Application (2018-2023)
4.2.3 Global Flu Vaccine Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Flu Vaccine Sales Breakdown by Application (2018-2023)
4.3.2 Europe Flu Vaccine Sales Breakdown by Application (2018-2023)
4.3.3 Asia-Pacific Flu Vaccine Sales Breakdown by Application (2018-2023)
4.3.4 Latin America Flu Vaccine Sales Breakdown by Application (2018-2023)
4.3.5 Middle East and Africa Flu Vaccine Sales Breakdown by Application (2018-2023)
5 North America Flu Vaccine by Country
5.1 North America Flu Vaccine Historic Market Size by Country
5.1.1 North America Flu Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Flu Vaccine Sales in Volume by Country (2018-2023)
5.1.3 North America Flu Vaccine Sales in Value by Country (2018-2023)
5.2 North America Flu Vaccine Forecasted Market Size by Country
5.2.1 North America Flu Vaccine Sales in Volume by Country (2024-2029)
5.2.2 North America Flu Vaccine Sales in Value by Country (2024-2029)
6 Europe Flu Vaccine by Country
6.1 Europe Flu Vaccine Historic Market Size by Country
6.1.1 Europe Flu Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Flu Vaccine Sales in Volume by Country (2018-2023)
6.1.3 Europe Flu Vaccine Sales in Value by Country (2018-2023)
6.2 Europe Flu Vaccine Forecasted Market Size by Country
6.2.1 Europe Flu Vaccine Sales in Volume by Country (2024-2029)
6.2.2 Europe Flu Vaccine Sales in Value by Country (2024-2029)
7 Asia-Pacific Flu Vaccine by Region
7.1 Asia-Pacific Flu Vaccine Historic Market Size by Region
7.1.1 Asia-Pacific Flu Vaccine Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Flu Vaccine Sales in Volume by Region (2018-2023)
7.1.3 Asia-Pacific Flu Vaccine Sales in Value by Region (2018-2023)
7.2 Asia-Pacific Flu Vaccine Forecasted Market Size by Region
7.2.1 Asia-Pacific Flu Vaccine Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Flu Vaccine Sales in Value by Region (2024-2029)
8 Latin America Flu Vaccine by Country
8.1 Latin America Flu Vaccine Historic Market Size by Country
8.1.1 Latin America Flu Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Flu Vaccine Sales in Volume by Country (2018-2023)
8.1.3 Latin America Flu Vaccine Sales in Value by Country (2018-2023)
8.2 Latin America Flu Vaccine Forecasted Market Size by Country
8.2.1 Latin America Flu Vaccine Sales in Volume by Country (2024-2029)
8.2.2 Latin America Flu Vaccine Sales in Value by Country (2024-2029)
9 Middle East and Africa Flu Vaccine by Country
9.1 Middle East and Africa Flu Vaccine Historic Market Size by Country
9.1.1 Middle East and Africa Flu Vaccine Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Flu Vaccine Sales in Volume by Country (2018-2023)
9.1.3 Middle East and Africa Flu Vaccine Sales in Value by Country (2018-2023)
9.2 Middle East and Africa Flu Vaccine Forecasted Market Size by Country
9.2.1 Middle East and Africa Flu Vaccine Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Flu Vaccine Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Sanofi Pasteur
10.1.1 Sanofi Pasteur Company Information
10.1.2 Sanofi Pasteur Introduction and Business Overview
10.1.3 Sanofi Pasteur Flu Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.1.4 Sanofi Pasteur Flu Vaccine Products Offered
10.1.5 Sanofi Pasteur Recent Development
10.2 CSL
10.2.1 CSL Company Information
10.2.2 CSL Introduction and Business Overview
10.2.3 CSL Flu Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.2.4 CSL Flu Vaccine Products Offered
10.2.5 CSL Recent Development
10.3 GSK
10.3.1 GSK Company Information
10.3.2 GSK Introduction and Business Overview
10.3.3 GSK Flu Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.3.4 GSK Flu Vaccine Products Offered
10.3.5 GSK Recent Development
10.4 Mylan
10.4.1 Mylan Company Information
10.4.2 Mylan Introduction and Business Overview
10.4.3 Mylan Flu Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.4.4 Mylan Flu Vaccine Products Offered
10.4.5 Mylan Recent Development
10.5 Hulan Bio
10.5.1 Hulan Bio Company Information
10.5.2 Hulan Bio Introduction and Business Overview
10.5.3 Hulan Bio Flu Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.5.4 Hulan Bio Flu Vaccine Products Offered
10.5.5 Hulan Bio Recent Development
10.6 AstraZeneca
10.6.1 AstraZeneca Company Information
10.6.2 AstraZeneca Introduction and Business Overview
10.6.3 AstraZeneca Flu Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.6.4 AstraZeneca Flu Vaccine Products Offered
10.6.5 AstraZeneca Recent Development
10.7 CCBIO
10.7.1 CCBIO Company Information
10.7.2 CCBIO Introduction and Business Overview
10.7.3 CCBIO Flu Vaccine Sales, Revenue and Gross Margin (2018-2023)
10.7.4 CCBIO Flu Vaccine Products Offered
10.7.5 CCBIO Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Flu Vaccine Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Flu Vaccine Industrial Chain Analysis
11.4 Flu Vaccine Market Dynamics
11.4.1 Flu Vaccine Industry Trends
11.4.2 Flu Vaccine Market Drivers
11.4.3 Flu Vaccine Market Challenges
11.4.4 Flu Vaccine Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Flu Vaccine Distributors
12.3 Flu Vaccine Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
